Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial

NCT06647459 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT06647459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06647459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial
Lead sponsor
Vanderbilt University Medical Center
Phase
Observational
Overall status
Terminated
Start date
December 13, 2023
Completion date
April 28, 2026
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, ventricular tachycardia